To make things easier, leave this box checked On shared devices, we recommend that you disconnect from Euroquity when you are done
Email

You will receive an email to define a new password

Location

Select your country

and your language

Hi ,

Welcome to your personnel profile page! Fill in your information in order to become more visible to organizations that interest you.

% completed

%

medal 1
This profile is validated by 1 label.

Company

Indicate Solutions

Indicate Solutions_logo
20
EQ SCORE

The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.

Indicate Solutions is working on a novel platform nucleic acid detection technology based on nanoparticles to identify coronavirus infected patients rapidly (<30 mins) in a easy-to-use solution kit format to be used whenever and wherever needed.

Donostia-San Sebastián, Gipuzkoa, Spain

Send a message

  • 3

    employees

  • €0

    turnover

English

Indicate Solutions

English

Indicate Solutions, S.L. was set up in 2016 to exploit and commercialise the IP generated by the INDICATE (IN vitro DIagnostic CAncer TEst) project . The concept behind the INDICATE project was simple; to create a rapid nucleic acid test (NAT) as a single-use handheld POC device, similar in format and cost to pregnancy tests but used to detect actionable mutations in the blood of cancer patients.

...
See more

Indicate Solutions, S.L. was set up in 2016 to exploit and commercialise the IP generated by the INDICATE (IN vitro DIagnostic CAncer TEst) project . The concept behind the INDICATE project was simple; to create a rapid nucleic acid test (NAT) as a single-use handheld POC device, similar in format and cost to pregnancy tests but used to detect actionable mutations in the blood of cancer patients.

 

In other words, our objective is to be the ClearBlue™ of diagnostics. 

 

The INDICATE project  was originally conceived in 2013 by Charles Lawrie of Biodonostia, and Luis Liz-Marzán and Marek Gzelczak of CIC biomaGUNE in Donostia-San Sebastián, Spain. 

 

Indicate Solutions is dedicated to developing handheld economic single use rapid nucleic acid tests (NAT) in order to revolutionise current diagnostic practices. Imagine a scenario where patients can monitor their response to treatments and the progress of their diseases in the comfort of their own home, or at the pharmacy or in their local doctors sugery. Imagine being able to diagnose SARS-CoV-2, HIV or Ebola immidiately and wherever and whenever you need, without the need for electricity or other infrastructure.

 

In response to the global COVID-19 crisis, Indicate Solutions has conceived a Sars2 rapid test called REPViT. 

 

Tests is based on the same principles as the pregnancy test for which Indicate Solutions is now seeking funding to advance development to a pre-commercialisation stage in the next 6 months.

  • 1

    Like

Our latest news

Certifications

InvestHorizon - Accelerated
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.  This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential. InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
160 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
1151 Members

Our history

Start in Begining of the Story

  • Begining of the Story

    Indicate Solutions was formed in 2016 to commercialise the Intellectual Property (IP) generated.

  • We were granted with the IP

    Indicate Solutions has an exclusive licence to commercialise the IP of the patent.

  • Filled new EPO Patent

    In response to COVID-19 crisis, Indicate has conceived a Sars2 rapid test. Filled EPO patent.

to be continued ...